Respiratory Tract Infections
Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases.
Subtype terms (24)
More specific conditions that are subtypes of Respiratory Tract Infections in the MeSH hierarchy.
- Allergic Fungal Sinusitis
1 drug approved
- Bovine Respiratory Disease Complex
- Bronchitis
90 drugs (47 approved, 43 experimental)
- Common Cold
75 drugs (36 approved, 39 experimental)
- Empyema, Pleural
11 drugs approved
- Influenza, Human
334 drugs (78 approved, 256 experimental)
- Laryngitis
4 drugs (3 approved, 1 experimental)
- Legionellosis
- Lung Abscess
4 drugs approved
- Lung Diseases, Fungal
5 drugs (4 approved, 1 experimental)
- Lung Diseases, Parasitic
- Pharyngitis
83 drugs (53 approved, 30 experimental)
- Pleurisy
3 drugs approved
- Pneumonia
284 drugs (176 approved, 108 experimental)
- Rhinitis
67 drugs (45 approved, 22 experimental)
- Rhinoscleroma
4 drugs approved
- Severe Acute Respiratory Syndrome
158 drugs (76 approved, 82 experimental)
- Sinusitis
152 drugs (106 approved, 46 experimental)
- Supraglottitis
- Tracheitis
- Tuberculosis, Laryngeal
- Tuberculosis, Pleural
1 drug approved
- Tuberculosis, Pulmonary
96 drugs (61 approved, 35 experimental)
- Whooping Cough
45 drugs (31 approved, 14 experimental)
Drugs by status
Approved for this indication (41)
- ambroxol
- oak extract
- aztreonam
- Bacterial Lysates
- cefazolin
- cefmetazole
- cefotaxime
- cefotetan
- cefotiam
- cefoxitin
- ceftazidime
- astragalus membranaceus
- clavulanate
- erdosteine
- carbocisteine lysine
- amoxicillin
- ceftriaxone
- vancomycin
- ciprofloxacin
- ticarcillin
- cefoperazone
- dimetindene
- xiebai
- clindamycin
- carbomycin
- cefaclor
- ceforanide
- cefalotin
- cefradine
- troleandomycin
- +11 more
Phase 4 trials (65)
- diclofenac
- montelukast
- propofol
- vitamin d3
- urea
- bacille calmette-guerin
- procaine benzylpenicillin
- ketamine
- prednisone
- echinacea
- ergoferon
- ethambutol
- fufangshuanghua
- guaifenesin
- rifampin
- beclomethasone
- icosapent ethyl
- jing fang bai du san
- jinyebaidu
- fuganlin
- nimesulide
- oseltamivir
- piperacillin
- pneumococcal 13-valent conjugate vaccine
- acetaminophen
- lidocaine
- streptokinase
- ribavirin
- rifabutin
- acetylsalicylic acid
- +35 more
Phase 3 trials (73)
- phenylephrine
- sodium nitrite
- ceftaroline fosamil
- ag npp709
- Ziresovir
- bifidobacterium animalis
- das181
- dexchlorpheniramine maleate
- ibuprofen
- selinexor
- garlic
- ginseng
- zanamivir
- RSVPreF3
- hydroxychloroquine
- ritonavir
- histamine
- j022x
- Rilematovir
- lenzilumab
- kefir
- levamisole
- loxoprofen
- meglumine
- miglyol oil
- vitamin c
- sodium deoxyribonucleate
- cow milk
- pelubiprofen
- interferon alfa-1b
- +43 more
Phase 2 trials (57)
- hydrocodone
- 23-valent pneumococcal polysaccharide vaccine
- 131 iodine
- beetroot juice
- tobramycin
- cetylpyridinium chloride
- dornase alfa
- glucose oxidase
- flulaval
- dolutegravir
- tenofovir
- insulin human
- nitrogen
- lamivudine
- nitric oxide
- omadacycline
- omega interferon
- aluminum hydroxide
- anidulafungin
- ri-001
- rimantadine
- sulfamethoxazole
- everolimus
- emtricitabine
- gla-se
- vapendavir
- ad26.rsv.pref
- gentamicin
- budesonide
- oxygen
- +27 more
Phase 1 trials (35)
- abacavir
- acetylcysteine
- bacillus clausii
- benzydamine
- danirixin
- doxylamine
- fvh1
- gepotidacin
- gsk580416
- hyperpolarized helium
- xenon-129
- medi-534
- pf-04287881
- polyglucosamine
- epinephrine
- wobenzyme
- ad26.rsv.fa2
- ad35.rsv.fa2
- mf59
- sendai virus vaccine
- cefuroxime
- meningococcal (groups A, C, Y, W) tetanus toxoid conjugate vaccine
- moxifloxacin
- sargramostim
- flurbiprofen
- btz-043
- Protein Based Pneumococcal Vaccine
- polyriboinosinic acid
- polyribocytidylic acid
- qingfei
- +5 more
Other trials (32)
- vitamin e
- banlangen
- vitis vinifera
- ferrous fumarate
- kagocel
- nystatin
- beta-glucans
- human milk
- pneumostem
- procalcitonin
- sivelestat
- nicotinamide
- amphotericin b
- azficel-T
- autologous microbiome
- fructo-oligosaccharide
- gs-3k8
- betahistine mesilate
- maple syrup
- bacillus subtilis
- streptococcus salivarius
- walnut
- allium cepae
- multivitamins
- viusid
- temafloxacin
- hexylresorcinol
- xylometazoline
- ymc026
- lactobacillus reuteri
- +2 more
Organizations
Organization Involved with Phase 4 Indications (89)
- Adams Respiratory Therapeutics
- McNeil
- Perrigo
- Sanofi
- Novartis
- Almirall
- CPL Associates
- Guangzhou Yipinhong Pharmaceutical CO.,LTD
- Hamilton Health Sciences Corporation
- Valenta Pharm JSC
- Yakult Honsha Co., LTD
- Xiangbei Welman Pharmaceutical Co., Ltd
- Amarin
- Boehringer Ingelheim
- National Institute of Allergy and Infectious Diseases (NIAID)
- Dr. Sami Ulus Children's Hospital
- Central South University
- CES University
- Chronic Obstructive Pulmonary Disease Trial Network, Denmark
- China Academy of Chinese Medical Sciences
- Corporacion Ecuatoriana de Biotecnologia
- Harvard University
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Guangxi Medical University
- Helse Møre og Romsdal HF
- Katholieke Universiteit Leuven
- Kaiser Permanente
- McMaster University
- Medical University of Warsaw
- Menzies School of Health Research
- +59 more
Organization Involved with Phase 3 Indications (88)
- Pierre Fabre
- CV Therapeutics
- Gilead Sciences
- MedImmune
- Wyeth
- Ansun Biopharma, Inc.
- Bioforce AG
- FGK Clinical Research GmbH
- InQpharm Group
- Materia Medica Holding
- Medicago
- SocraTec R&D GmbH
- Vakzine Projekt Management GmbH
- Valio Ltd
- Ahn-Gook Pharmaceuticals Co.,Ltd
- Daewon Pharmaceutical Co., Ltd.
- Cystic Fibrosis Foundation Therapeutics
- National Cancer Institute (NCI)
- National Health Service, United Kingdom
- National Heart, Lung, and Blood Institute (NHLBI)
- National Institute of Child Health, Hungary
- University of Pittsburgh
- Cairo University
- University of London
- Federal University of Bahia
- Emory University
- Federal University of Rio Grande do Sul
- Georgetown University
- Hanyang University
- Indian Council of Medical Research
- +58 more
Organization Involved with Phase 2 Indications (99)
- PPD
- Ablynx
- Eisai
- AstraZeneca
- Aviragen Therapeutics
- Cerecor Inc
- Enanta Pharmaceuticals
- Immune Design
- INC Research
- Inovio Pharmaceuticals
- Lung Biotechnology PBC
- Nektar Therapeutics
- Novoteris, LLC
- Nventa Biopharmaceuticals Corporation
- Polyphor Ltd.
- Probi AB
- ADMA Biologics, Inc.
- Amarillo Biosciences, Inc.
- Biontech
- Chong Kun Dang Pharmaceutical
- National Institutes of Health (NIH)
- National Institute on Aging (NIA)
- National Institute on Deafness and Other Communication Disorders (NIDCD)
- Clinical Evaluation Research Unit at Kingston General Hospital
- Umeå University
- Cornell University
- Eastern Virginia Medical School
- Institut National de la Santé Et de la Recherche Médicale, France
- Johns Hopkins University
- Lviv National Medical University
- +69 more
Organization Involved with Phase 1 Indications (20)
- Crucell
- Biosearch S.A.
- Efranat Ltd.
- National Institute of Dental and Craniofacial Research (NIDCR)
- University of Manitoba
- University of Washington
- University of Louisville
- Tsinghua University
- Quotient
- University of Missouri
- Canadian Science Centre for Human and Animal Health
- National Microbiology Laboratory, Canada
- Pennsylvania State University
- National Autonomous University of Mexico
- Technical University of Munich
- Tianjin Cansino Biotechnology Inc
- Health Sciences Centre Foundation, Manitoba
- Consumer Healthcare Products Association
- National Honey Board
- Global Life Technologies Corp.
Organization Involved with Other Experimental Indications (42)
- Zarbee's Inc.
- Danisco
- Fundacion Infant
- National Center for Complementary and Integrative Health (NCCIH)
- World Health Organization
- Chr Hansen
- Noos S.r.l.
- Ain Shams University
- Hormozgan University of Medical Sciences
- Indiana University
- Liverpool John Moores University
- NHS Lothian
- Rutgers University
- Tel Hai College
- University of Medicine and Dentistry of New Jersey
- University of Nottingham
- University of Southern Denmark
- University of Tampere
- University of Zagreb
- Chonbuk National University
- Statens Serum Institut
- University of Copenhagen
- University of Utah
- All India Institute of Medical Sciences
- Bar Ilan University
- Hebrew University
- Government of Pakistan
- CPS Research
- Advanced Clinical Research Inc.
- Winthrop University
- +12 more